alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     IMTEC, Inc., EX-27, FDS for 10-Q, December 31, 1995
</LEGEND>
<CIK>                         0000730045
<NAME>                        IMTEC, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     US
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              JUN-30-1996
<PERIOD-START>                                 JUL-01-1995
<PERIOD-END>                                   DEC-31-1995
<EXCHANGE-RATE>                                1
<CASH>                                         351894
<SECURITIES>                                   300000
<RECEIVABLES>                                  1242405
<ALLOWANCES>                                   101825
<INVENTORY>                                    1319968
<CURRENT-ASSETS>                               3387113
<PP&E>                                         3519419
<DEPRECIATION>                                 2411866
<TOTAL-ASSETS>                                 4870564
<CURRENT-LIABILITIES>                          1023909
<BONDS>                                        0
<COMMON>                                       14789
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<OTHER-SE>                                     2227102
<TOTAL-LIABILITY-AND-EQUITY>                   4870564
<SALES>                                        4764384
<TOTAL-REVENUES>                               4764384
<CGS>                                          1746047
<TOTAL-COSTS>                                  2685783
<OTHER-EXPENSES>                               1395976
<LOSS-PROVISION>                               3000
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                695445
<INCOME-TAX>                                   275850
<INCOME-CONTINUING>                            419595
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   419595
<EPS-PRIMARY>                                  0.27
<EPS-DILUTED>                                  0.27
        


</TABLE>
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FROM THE JUNE
30, 1997 FORM 10-Q REPORT AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                       4,734,000
<SECURITIES>                                         0
<RECEIVABLES>                                6,076,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            10,810,000
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             137,569,000
<CURRENT-LIABILITIES>                       13,968,000
<BONDS>                                      9,982,000
<PREFERRED-MANDATORY>                                0 
<PREFERRED>                                          0
<COMMON>                                       316,000
<OTHER-SE>                                  82,123,000
<TOTAL-LIABILITY-AND-EQUITY>               137,569,000
<SALES>                                              0
<TOTAL-REVENUES>                             5,058,000
<CGS>                                                0
<TOTAL-COSTS>                                1,707,000
<OTHER-EXPENSES>                             2,175,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             420,000
<INCOME-PRETAX>                                756,000
<INCOME-TAX>                                   326,000
<INCOME-CONTINUING>                            430,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   430,000
<EPS-PRIMARY>                                    (.04)
<EPS-DILUTED>                                    (.04)
        

</TABLE>
----

            COMMISSION REGULATION (EC) No 450/2005

of 18 March 2005         

on proof that customs formalities for importation of milk and milk products in third countries have been completed as provided for in Article 16 of Regulation (EC) No 800/1999

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EC) No 1255/1999 of 17 May 1999 on the common organisation of the market in milk and milk products (1), and in particular the third indent of Article 31(10) thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

1.   In the case of exports of products falling within CN codes 0401 to 0405 carried out under Article 31 of Regulation (EC) No 1255/1999 for which the exporter is unable to provide the proof referred to in Article 16(1) and (2) of Regulation (EC) No 800/1999, products shall, by derogation from that Article, be deemed to have been imported into a third country on presentation of the following three documents:

2.   For the purposes of applying Article 20 of Regulation (EC) No 800/1999 Member States shall take into account the provisions laid down in paragraph 1.

Article 2

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union.

It shall apply to export declarations accepted from 1 January 2005 until 31 December 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 18 March 2005.

For the Commission

Mariann FISCHER BOEL            

Member of the Commission

----

(1)OJ L 160, 26.6.1999, p. 48. Regulation last amended by Commission Regulation (EC) No 186/2004 (OJ L 29, 3.2.2004, p. 6).

(2)OJ L 60, 27.2.2004, p. 46.

(3)OJ L 102, 17.4.1999, p. 11. Regulation last amended by Regulation (EC) No 671/2004 (OJ L 105, 14.4.2004, p. 5).

(4)OJ L 83, 20.3.2004, p. 4.

----
- PEPFAR Home
- About Us
- Our Priorities
- Where We Work
- Results and Impact
- Partnerships
- Remarks and Releases
- Reports and Guidance

HomeThe United States President’s Emergency Plan for AIDS Relief...PEPFAR at the 77th Session of the U.N. General Assembly and the Global Fund Replenishment Conference

# 									PEPFAR at the 77th Session of the U.N. General Assembly and the Global Fund Replenishment Conference							

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is participating in events as part of the 77th session of the United Nations General Assembly (UNGA). During the UNGA High-Level Week (September 20-26, 2022), PEPFAR will engage in discussions about the state of the global HIV/AIDS response, particularly in the context of the COVID-19 pandemic; dedicated efforts to address core HIV/AIDS-related comorbidities, including cervical cancer for women living with HIV/AIDS; the critical role of faith communities in supporting children and adolescents living with and affected by HIV/AIDS; and the vital contributions of resilient and responsive health systems and health care workforces to HIV progress and broader pandemic preparedness and response.

Along the sidelines of UNGA in New York, the U.S. is hosting the Global Fund’s Seventh Replenishment Conference September 18-21. The Global Fund raises and invests money in three-year cycles known as Replenishments. The Global Fund aims to raise at least $18B during this year’s pledging conference to strengthen health systems and help low- and middle-income countries get back on track to end HIV/AIDS, tuberculosis and malaria as public health threats by 2030. The success of the Replenishment helps to advance U.S. foreign policy interests in the area of health equity and global health security.

*Interested in joining the conversation? Follow PEPFAR’s latest updates on Twitter.*

*Stay tuned to this page for updates during the UNGA High-Level Week (September 20-26) and Global Fund Seventh Replenishment Conference (September 18-21).*

#### *Share America* Article: *Building on the U.N.’s success*

Ahead of UNGA, the U.S. Department of State published this ShareAmerica article highlighting the U.S. delegation’s work to advance global health and security and the Global Fund Seventh Replenishment Conference that aims to get the world back on track to end HIV, tuberculosis and malaria.

#### Video: *Advancing Global Health Security*

This U.S. Department of State video highlights the U.S. delegation’s global health goals.

#### Picture Slideshow: PEPFAR at  UNGA 77 and Global Fund Seventh Replenishment

Tags

Global HealthGlobal HealthThe United States President’s Emergency Plan for AIDS ReliefU.S. President's Emergency Plan for AIDS ReliefUNGA 77United Nations

Back to Top
**
**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGEACT OF 1934,**

**AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Christopher Visioli, certify that: 

 
1.
I have reviewed this Annual Report on Form 10-K/A of Population HealthInvestment Co., Inc.; 

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 
 (a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to bedesigned under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report isbeing prepared; 

 
 (b)
[Omitted]; 

 
 (c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 
 (d)
Disclosed in this report any change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internalcontrol over financial reporting; and 

 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 
 (a)
All significant deficiencies and material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 
 (b)
Any fraud, whether or not material, that involves management or other employees who have a significant role inthe registrant’s internal control over financial reporting. 

 
Date: January 7, 2022  By: /s/ Christopher Visioli   **Christopher Visioli**   **Chief Financial Officer**   **(Principal Financial Officer)****
I 

110TH CONGRESS 

1ST SESSION H. R. 18 

To provide for the issuance of a commemorative postage stamp in honor 

of Rosa Parks. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 4, 2007 

Mr. RUSH (for himself, Mr. UPTON, and Mr. CONYERS) introduced the following bill; which was referred to the Committee on Oversight and Government Reform 

A BILL 

To provide for the issuance of a commemorative postage 

stamp in honor of Rosa Parks. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ROSA PARKS COMMEMORATIVE POSTAGE 

4 STAMP. 

5 (a) IN GENERAL.—The Postmaster General shall 

6 issue a commemorative postage stamp in honor of Rosa 

7 Parks. 

8 (b) DENOMINATION; DESIGNS.—The commemorative 

9 postage stamp issued under this Act shall be issued in the 

10 denomination used for first class mail up to one ounce in 


sroberts on PROD1PC70 with BILLS
2 

•HR 18 IH

1 weight and shall bear such designs as the Postmaster Gen2 eral shall determine. 

3 (c) ISSUANCE PERIOD.—The commemorative postage 

4 stamp issued under this Act shall be placed on sale as 

5 soon as practicable after the date of the enactment of this 

6 Act and shall be sold for such period thereafter as the 

7 Postmaster General shall determine. 

Æ 


sroberts on PROD1PC70 with BILLS
12/17/2014 Page of



### POST FOCUS REVIEW EXPOSURE REPORT

Chemical ID: P -15-0001 Reviewer: Tobas/BC

Results Table: Dose, Concentration, and Days Exceeded Results Summary

Exposure Scenario 1 Water Landfill Stack Air Fugitive Air

Release activity(ies) 2 ;

exposure c alculation(s) 3 Drinking Water Fish Ingestion 7Q10 4

CC =18 PDM

Days

Exceeded LADD ADR LADD ADR LADD

ADR LADD ADR LAD D

mg/kg/day mg/kg/day mg/kg/day mg/kg/day μg/l # Days mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg/day

max acute eco

--- --- --- --- 1.48E+00

--- --- --- --- --- ---

1 Exposure scenario titles consist of release activity followed by expos ure calculation abbreviation.

2 Release activities are from engineering report's Manufacturing (Mfg), Processing (Proc) and Use release activity labels.

Multiple release activities are combined in one exposure scenario if their releases occur at same loc ation.

3 Exposure calculations are Acute Dose Rate (ADR), Lifetime Average Daily Dose (LADD), and Probabilistic Dilution

Model (PDM). There may be one, two, or all three exposure calculations per exposure scenario.

CC is the aquatic concentration of concern.

4 This column displays concentration values for the 7Q10 streamflow, which is defined as the average daily streamflow

of the seven consecutive days of lowest flow within a ten year period.

Remarks :12/17/2014 Page of

POST FOCUS REVIEW EXPOSURE REPORT

C hemical ID : P- 15

- 0001 Assessor: Tobas/BC

ENVIRONMENTAL RELEASES

Scenario#: 1 Number of Release Sites:

Release Activity: Max ADR

Release Description: WATER LANDFILL

Non

- sludge/Sludge STACK FUGITIVE

Total Releases:

(kg/yr) (kg/yr) (kg/yr) (kg/yr)

Non

- sludge/Sludge

Release Days/yr:

Per Site Release:

(kg/site/day) (kg/site/day ) (kg/site/day) (kg/site/day)

Remarks:12/17/2014 Page of

POST FO CUS REVIEW EXPOSURE REPORT

Chemical ID : P- 15

- 0001

SI TE

- SPECIFIC HUMAN AND AQUATIC EXPOSURES TO SURFACE WATER RELEASES

SCENARIO NUMBER: 1 RELEASE ACTIVITY: Max ADR

FACILITY NAME:

FACILITY LOCATION:

RECEIVING WATER NAME:

REACH NUMBER: FACILITY ON REACH: DISCHARGE TYPE:

NPDES PERMIT #: EXPOSED POPULATION: Adult

WWT

REMOVAL

(%) RELEASE

DAYS PRETREATMENT

RELEASE

(kg/site/day) POSTTREATMENT

RELEASE

(kg/site/day) D WT

(%) BCF

(L/kg)

0.00 0.00

AQUATIC EXPOSURE ESTIMATES

- SURFACE WATER

FLOW DESCRIPTOR Harmonic Mean 30Q5 7Q10 1Q10 PLANT

FLOW (MLD)

CONCENTR ATION (μg/L) 0.51 0.97 1.48 1.81 NA

DRINKING WATER INGESTION AND FISH INGESTION EXPOSURE ESTIMATES

Exposure Units Drinking Water

Results Drinking Water

Units Fish Ingestion

Results Fish Ingestion

Units

Cancer

LADD pot 6.13E

- 08 mg/kg/day 0.00 mg/kg/d ay

LADC pot 4.72E

- 06 mg/L 0.00 mg/kg

Acute

ADR pot 3.67E

- 05 mg/kg/day 0.00 mg/kg/day

Surface Water Comments:
#### Eureka Fire Hose Company, respondent, *v.*Eureka Rubber Manufacturing Company, appellant.

[Argued March 8th, 1906.

Decided November 19th, 1906.]

On appeal from a decree of the court of chancery advised by Vice-Chancellor Emery, whose opinion is reported, in *<6& N. J. Eq. 159. ■*.

*Mr. John’V. B.*Wicojf, for. the appellant.

*Messrs. Crouse*cC Perhins, for the respondent.

*301.Per Curiam.

Tbe decree appealed from is affirmed, for the reasons stated in the opinion filed in the court of chancery by Vice-Chancellor Emery.

*For*affirmance—Garrison, Port, Garketson, Hendrickson, Pitney, Swayze, Bogert, Vredenburgi-i, Vroom, Gray—10.

*For*reversal—None.
exv10w3



 


Exhibit 10.3


Michele J. Langstaff has entered into a Change in Control Agreement that is
substantially identical in all material respects to the agreement with Paul F.
Walsh that was filed as Exhibit 10.2 to the Company’s Quarterly Report on Form
10-Q for the quarter ended September 30, 2002.
#### § 303.1 [Reserved]
§ 302.1 Public records and access. ( a ) *Inspection.* Records of proceedings before the Board will be available for public inspection at the Copyright Royalty Board offices.
( b ) *Requests.* Requests for access to records must be directed to the Copyright Royalty Board. No requests for information or access to records shall be directed to or accepted by a Copyright Royalty Judge. Access to records is only available by appointment.
Certain executive officer compensation information regarding cash bonuses



 Exhibit 10.30 
 Health Management Associates, Inc. 
 Certain Executive Officer Compensation Information

 Effective February 24, 2009, Health Management Associates, Inc. (the “Company”) finalized the determination of cash
bonuses to certain of its named executive officers. Those bonuses, which pertain to the Company’s annual and long-term incentive compensation programs for the year ended December 31, 2008, were approved by the Compensation Committee of the
Board of Directors of the Company. The table below summarizes those bonuses. 
  

							
	 Executive Officer
	  	Annual Cash
Bonus	  	Long-Term Incentive
Compensation Cash
Bonus
	 Robert E. Farnham,
Senior Vice President and Chief Financial Officer
	  	$	235,000	  	$	14,583
			
	 Kelly E. Curry,
Executive Vice President and Chief Administrative Officer
	  	$	396,563	  	$	35,156
			
	 Timothy R. Parry,
Senior Vice President, General Counsel and Corporate Secretary
	  	$	205,625	  	$	9,115

 The cash bonuses described above were made under the Company’s Amended and Restated 1996
Executive Incentive Compensation Plan (the “EICP”), a comprehensive executive compensation plan in which the Company’s named executive officers, among others, may participate. A summary of the EICP is contained in the Company’s
definitive proxy statement dated March 31, 2008 under the heading “Proposal Two: Proposal to Amend and Restate the Health Management Associates, Inc. 1996 Executive Incentive Compensation Plan – Summary of the EIPC,” which
summary is incorporated herein by reference. Such description is qualified in its entirety by reference to the actual EICP, which can be found at Exhibit A to the Company’s definitive proxy statement dated March 31, 2008. Additionally, the
form of Cash Performance Award under the EICP relating to the long-term incentive compensation cash bonuses disclosed in the above table can be found at Exhibit 10.26 to the Company’s Annual Report on Form 10-K for the year ended
December 31, 2008.
```

[Federal Register Volume 82, Number 6 (Tuesday, January 10, 2017)]
[Notices]
[Pages 3071-3072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-00180]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Thirty First RTCA 216 Aeronautical Systems Security Plenary

AGENCY: Federal Aviation Administration (FAA), U.S. Department of 
Transportation (DOT).

[[Page 3072]]

ACTION: Thirty First RTCA 216 Aeronautical Systems Security Plenary.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a 
meeting of Thirty First RTCA 216 Aeronautical Systems Security Plenary.

DATES: The meeting will be held February 06-10, 2017 09:00 a.m.-05:00 
p.m. PLEASE NOTE: All attendees must pre-register by contacting Karan 
Hofmann at khofmann@rtca.org or 202-330-0680.

ADDRESSES: The meeting will be held at: Honeywell, 21111 N. 19th Ave, 
Phoenix, AZ 85027.

FOR FURTHER INFORMATION CONTACT: Karan Hofmann at khofmann@rtca.org or 
202-330-0680, or The RTCA Secretariat, 1150 18th Street NW., Suite 910, 
Washington, DC 20036, or by telephone at (202) 833-9339, fax at (202) 
833-9434, or Web site at http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.), notice is 
hereby given for a meeting of the Thirty First RTCA 216 Aeronautical 
Systems Security Plenary. The agenda will include the following:
Monday, February 6, 2017--9:00 a.m.-5:00 p.m.
    1. Welcome and Administrative Remarks
    2. Introductions
    3. Agenda Review
    4. Meeting-Minutes Review
    5. Review Joint Action List
    6. Review White Papers (Status and intent of those planned and 
produced; Gain common understanding of intent; Resolve differences)
    7. Schedule Update
    8. Date, Place and Time of Next Meeting
    9. New Business
    10. Adjourn Plenary
Tuesday, February 7, 2017--9:00 a.m.-5:00 p.m.
    Continuation of Plenary or Working Group Sessions
Wednesday, February 8, 2017--9:00 a.m.-5:00 p.m.
    Continuation of Plenary or Working Group Sessions
Thursday, February 9, 2017--9:00 a.m.-5:00 p.m.
    Continuation of Plenary or Working Group Sessions
Friday, February 10, 2017--9:00 a.m.-12:00 p.m.
    Continuation of Plenary or Working Group Sessions
    Attendance is open to the interested public but limited to space 
availability. With the approval of the chairman, members of the public 
may present oral statements at the meeting. Persons wishing to present 
statements or obtain information should contact the person listed in 
the FOR FURTHER INFORMATION CONTACT section. Members of the public may 
present a written statement to the committee at any time.

    Issued in Washington, DC on January 4, 2017.
Mohannad Dawoud,
Management & Program Analyst, Partnership Contracts Branch, ANG-A17, 
NextGen, Procurement Services Division, Federal Aviation 
Administration.
[FR Doc. 2017-00180 Filed 1-9-17; 8:45 am]
 BILLING CODE 4910-13-P
```